Navigation Links
Natural Fuels Industries Eyes 'Biomass Rich' Georgia for Production Facility
Date:6/24/2009

MISSOULA, Mont., June 24 /PRNewswire-FirstCall/ -- VEGA PROMOTIONAL SYSTEMS, INC. (Pink Sheets: VGPR) today announced through its wholly owned subsidiary, Natural Fuels Industries, it is planning to construct a manufacturing facility in the State of Georgia to produce alternative energy from organic waste.

According to a recent Forbes Magazine article entitled "America's Best Places For Alternative Energy," the abundance of biomass in Georgia's Bioenergy Corridor ranks third in the nation as a potential source of renewable energy. The article referenced the amount of privately owned forest in Georgia, more than any other state in the country, as a reason for the state's ranking. Forbes also cited that roughly 50 million tons of the state's own timber ends up in the state's wood-products manufacturing plants every year and the industry returns nearly half of it in the form of primary mill wood debris.

"Georgia's wealth of natural resources combined with our research institutions and a strong business climate create an ideal environment for the development of renewable energy," said Georgia Governor, Sonny Perdue. "We appreciate Forbes' recognition of our ability to develop alternative energy sources."

The proposed Georgia facility would be designed to produce alternative/green energy. When completed, the plant would have the capacity to produce several hundred thousand metric tons of biomass fuel pellets annually. NFI recently announced it has entered into a Letter of Intent to purchase a 20% equity interest in a biomass manufacturing facility currently under construction in MAP Ta PHUT, Thailand.

Biomass or biofuel is material derived from recently living organisms. This includes plants, animals and their by-products. For example, manure, garden waste and crop residues are all sources of biomass. It is a

SOURCE Vega Promotional Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
2. Natural Nutrition Launches International Marketing Campaign for New All Natural Analgesic: BLUE LIGHTNING(TM) Fast Pain Relief
3. AGI Dermatics Clinical Data Identifies L-Ergothioneine as Part of Skins Natural Antioxidant System
4. FDA Clears First Medical Product Made From Yulex(R) Natural Rubber
5. The most natural drug
6. Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates
7. Zemea Propanediol Approved as a Natural Ingredient by ECOCERT
8. Botaneco receives natural ingredient approval from ECOCERT(R) for Hydresia(TM) G2
9. China Medicine to Showcase Bethin Weight Loss Product at 2008 Natural Products Expo East Trade Show
10. GenOdyssee Receives Broad Product Applications Protection in EU for Founding Natural Evolution Technology
11. PURE Bioscience and Ciba Strike New Contract for Natural Antimicrobial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , SANTA CRUZ, Calif., Nov. 24 /PRNewswire/ ...io Career Center, the nation,s leading online job ...als. ,, Northwestern and Columbia University ar...ajor life science training Institutions. ,, The... post-graduates in the life sciences. While there ...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November.... (Nasdaq: DCGN ) today announced that it has rece...ing in the company,s common stock will be,suspende...e filed with the,Securities and Exchange Commissio...sting on Nasdaq, unless the company files an appea...
(Date:11/24/2009)... Health care employment grew b...e only one to show consistent growth during the U....tals remain in trouble, and health systems are com...nnel, instead of just administrators. , ... care employment continued growing in October desp...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia/ --...& Trademark Office (PTO) has allowed the paten...or NOD technology. , NOD technology is a ...or,proteins into bio-adhesive nano-particles to en... as injections. NOD technology is a platform techn...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
... 26 Joseph F. Finn, Jr., C.P.A. ("Finn"), announc...erest from pharma companies in the intellectual pr.... , , In preclinical studies, GCS-100 inhibited b...s. Development and growth of solid tumors require...iver oxygen and nutrients to a tumor. Galectin-3 ...
...outstanding, world-changing leaders to participate...s of the TED Conference introduced today the 25 ne... international conference, TEDGlobal. These Fellow...ttending TEDGlobal 2009, to be held in Oxford, UK,...TED Fellows selected for the TED2009 Conference, h...
...ornia and AMSTERDAM, May 26 ,Agendia, a world lead...d the,opening of its U.S. clinical genomics labora...lly-licensed and compliant with the Clinical Labor...ed by the Centers for Medicare,and Medicaid Servic...ncer genomics laboratory, Agendia has,over the pas...
Other Biology Technology:Prospect Therapeutics, Inc.'s GCS-100 Inhibited Blood Vessel Formation in a Variety of Cancer Models 2TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford 2TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford 3TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford 4TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford 5Agendia Opens CLIA-Registered U.S. Genomics Laboratory 2Agendia Opens CLIA-Registered U.S. Genomics Laboratory 3
(Date:11/25/2009)...Head of the Cell Death Research Laboratory in the ...een awarded the prestigious Johnson & Johnson Focu...ause of brain cell damage in Parkinson,s disease. ...s in support of innovation and excellence in scien...d earlier this month at an event at the Hyatt Rege...
(Date:11/24/2009)...s it has been prescribed by traditional healers in...s and stomach pain to fever and flu. , Now for th...have been able to scientifically prove the pain re...known as Brazilian mint. , Testing this ancient S...cher Graciela Rocha was able to show that when pre...
(Date:11/24/2009)...on of a remarkable class of ring-shaped protein mo...wrence Berkeley National Laboratory (Berkeley Lab)...beamline at the Advanced Light Source (ALS). These...ion and replication, and are vital to the survival...ents, such as the human papillomavirus, which has ...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Got a pain? -- Have a cup of Brazilian mint 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 14702 1Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 14702 2Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 14702 3Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 14702 4Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 14702 5Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 14702 6Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update 14702 7Cancer Diagnostics Company On Q ity Raises 2421M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy 5961 1Cancer Diagnostics Company On Q ity Raises 2421M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy 5961 2Varian Inc to Release Fourth Quarter and Full Fiscal Year 2009 Financial Results 5957 1
...searchers at NYU Langone Medical Center may have d...ndrome (BTHS). BTHS, a sometimes fatal disease, is...y in males that leads to infection or heart failur...alcium-independent phospholipase A2 in the pathoge...n the Proceedings of the National Academy of Scie...
...N ARBOR, Mich. Researchers from the University of...ied a gene that is overexpressed in 90 percent of .... , Expression of the gene, Ataxia Telangiectasia...erage 20 times higher in pancreatic cancer cells t...the gene appears to make pancreatic cancer cells r...
... international team of scientists, led by Monash U...of a superbug that kills elderly hospital patients... save lives and health care systems billions of do...n the prestigious scientific journal Nature , unr...Clostridium difficile and solved the mystery surr...
Other Biology News:New potential therapeutic target discovered for genetic disorder -- Barth syndrome 2U-M researchers ID gene involved in pancreatic cancer 2Monash scientists debug superbug 2
Mouse Anti-Human Killer Cell Immunoglobulin-like Receptor, Two Domains, Long Cytoplasmic Tail, 2 (KIR2DL2 (KIR2DL3) Monoclonal Antibody, Unconjugated from Lifespan Biosciences
2,7-Dichlorofluorescein (Fluorescence Reference Standard) from AnaSpec
Mouse Anti-Human Relaxin-2, pro- Monoclonal Antibody, Unconjugated, Clone fred from Immundiagnostik
Mouse Anti-Human Kallikrein 2 Monoclonal Antibody, Unconjugated, Clone 6B7 from ImmuQuest Ltd.
Biology Products: